SCI Ventures is a pioneering fund dedicated to transforming the landscape of spinal cord injury treatments through innovative investment strategies. Backed by leading foundations in the US and Europe and advised by esteemed neuroscientists, SCI Ventures focuses on early-stage companies that are developing cure-oriented therapies for paralysis and related conditions. The fund operates with a unique venture philanthropy approach, combining philanthropic goals with the rigorous evaluation of a traditional VC fund.

Their investment portfolio includes pioneering firms like Onward Medical, which specializes in electrical stimulation therapies, Axonis Therapeutics, which develops small molecule drugs for neuron restoration, and Sania Therapeutics, known for its advanced gene therapy platform. These companies are at the forefront of research aimed at restoring movement and promoting neural regeneration.

With a commitment to accelerating the journey from the lab to clinical applications, SCI Ventures aims to prove that spinal cord injuries can be effectively treated, ultimately enhancing the quality of life for millions affected worldwide.